A global life sciences and diagnostics manufacturer sought to modernize and standardize its oligonucleotide synthesis operations across multiple facilities. Ascential delivered a unified, automated platform that improved reagent efficiency, reduced labor dependency, and enhanced system reliability which positioned the organization for scalable, cost-effective production.
Oligonucleotide synthesis is foundational to modern molecular biology, diagnostics, and therapeutics development. However, legacy systems (often sourced from multiple vendors) can introduce variability, inefficiencies, and operational complexity that limit scalability.
The client needed to consolidate and modernize its synthesis infrastructure to support growing demand and evolving applications. Key challenges included:
Unify synthesis processes across multiple facilities and legacy platforms
Replace outdated equipment with a system capable of supporting advanced chemistry and improved performance
Integrate disparate systems from different manufacturers into a single, cohesive platform
Reduce variability, labor requirements, and reagent waste while improving serviceability
Ascential designed and implemented a unified oligonucleotide column synthesizer system, replacing multiple legacy platforms with a single, upstream solution.
By applying a Design for Standardization approach, the team streamlined synthesis workflows and reduced system complexity across sites.
Key elements of the solution included:
This approach enabled tighter process control while creating a scalable foundation for future growth.
| Capability | What Ascential Built |
|---|---|
| Automated Synthesis Platform | Unified oligonucleotide column synthesizer system replacing multiple legacy platforms to standardize workflows across sites |
| Chemistry Integration | Updated chemistry and fluidic processes to support improved synthesis performance and consistency |
| Fluidics & Reagent Management | Automated fluid handling and reagent delivery designed to reduce waste and minimize manual intervention |
| Process Standardization | Design for standardization across facilities to reduce variability, improve repeatability, and streamline maintenance |
| Operational Scalability | Platform designed to support expanded throughput and consistent performance across multiple sites |
| Qualification & Deployment Support | System advanced into qualification trials to enable broader deployment and operational readiness |
Through system consolidation and standardization, the client achieved measurable improvements in operational performance:
As demand for molecular diagnostics, gene therapies, and advanced research tools continues to grow, the ability to standardize and scale oligonucleotide production is critical.
By transitioning from fragmented systems to a unified, automated platform, the client established a more efficient and resilient manufacturing model which enables faster innovation, improved quality, and long-term cost optimization.
For organizations operating in complex, regulated environments, this approach demonstrates how standardization and automation can unlock both operational efficiency and strategic advantage.
Looking to standardize and scale complex production workflows? Ascential partners with life sciences leaders to design, automate, and manufacture systems that accelerate commercialization while reducing risk.
Get Your 15-Minute Consultation
